Metabolic Engineering for Improved Liver Function
Metabolic Engineering for Improved Liver Function
批准号:
7526491
负责人:
Martin L Yarmush
金额:
$37.05万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-15 至 2012-06-30
关键词:
ATP Synthesis PathwayAcuteAgonistAmino AcidsAntioxidantsAutopsyBile fluidBiological PreservationBloodBlood CirculationBrainBrain DeathCadaverCalciumCardiac DeathCessation of lifeChronicComplexConditionCryopreservationDoseEnd Point AssayEngineeringEpidemicEvaluationEvolutionFatty LiverFluorescence MicroscopyGlucagonGoalsHarvestHeartHeat shock proteinsHeat-Shock ResponseHepatocyteIn SituIncidenceIndocyanine GreenInsulinInterventionLeadLengthLipidsLiverLiver DysfunctionLiver FailureLongitudinal StudiesMeasuresMembrane PotentialsMetabolicMetabolismMethodologyMethodsMitochondriaModalityMonitorNumbersObesityOperative Surgical ProceduresOrganOutcomeOxidation-ReductionOxygenPatientsPerfusionPeroxisome Proliferator-Activated ReceptorsPhysiologicalPostoperative PeriodProcessProductionProtocols documentationPublic HealthRateRattusReagentRecoveryRespirationRiskRisk FactorsRunningScreening procedureSolutionsSystemTechniquesTemperatureTestingTherapeuticTimeTissuesTransplantationVariantadipokinesbasecostheme oxygenase-1improvedin vivointravital microscopyliver biopsyliver functionliver transplantationmitochondrial membranenew technologyoxidationrepairedresponsesizesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Orthotopic liver transplantation (OLT) is a highly successful therapeutic modality for the treatment of both acute and chronic liver failure which is severely limited by the scarcity of donor livers. Among the livers donated after brain death, the most common single predisposing risk factor for postoperative liver failure is steatosis; thus, fatty livers are often considered to be "unacceptable" or "marginally acceptable" for transplantation. The incidence of hepatic steatosis is 10 to 25% based on autopsy studies and donor liver biopsies. It is clear that methods that would salvage discarded donors because of severe steatosis could significantly reduce the number of patient deaths, and help close the gap between supply and demand in liver transplantation. The overall hypothesis is that discarded donor livers, and more specifically steatotic livers (and in the long run donors after cardiac death), can be salvaged by perfusion with artificial solutions under well-controlled conditions and at physiological temperatures in order to promote defatting and cellular repair, and as a result made capable to withstand surgical procedures and reduce the risk of postoperative liver dysfunction to a level similar to that observed in normal livers. In the studies proposed herein, our objective is to apply this approach to fatty livers, and eventually to the more complex case of ischemic livers (i.e. from donors after cardiac death). Our specific aims are: (1) To optimize metabolism for defatting steatotic livers during normothermic or mild hypothermic perfusion; (2) To investigate the combined effects of heat shock and warm perfusion on microvascular function and transplantability in steatotic livers; (3) To develop a normothermic perfusion protocol that restores mitochondrial function and ATP stores in warm ischemic livers. In the short-term, the proposed studies could (a) provide the rationale basis for increasing the donor pool size; (b) improve the outcome of patients which receive marginal donor livers; (c) prolong the useful preservation time of steatotic, defatted, as well as warm ischemic livers. In the long-term, these studies will lead to (a) increased donor pool size and (b) increased organ storage time beyond the limits of current cold storage techniques. These outcomes will significantly alleviate donor shortage and lead the way to donor banking, with the potential to revolutionize donor liver allocation. PUBLIC HEALTH RELEVANCE: The proposed studies will provide basic scientific information and new technologies that will enable the recovery of donor livers that are otherwise rejected from the donor pool. In the long-term, these studies will lead to (a) increased donor pool size and (b) increased organ storage time beyond the limits of current cold storage techniques. These outcomes will significantly alleviate donor shortage and lead the way to donor banking, with the potential to revolutionize donor liver allocation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Portable automated device for rapid venous blood draws and point of care diagnostic analysis
-
批准号:9145737
-
项目类别:
-
资助金额:$69.63万
-
财政年份:2015
-
负责人:Martin L Yarmush
-
依托单位:
Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical En
-
批准号:8471108
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2012
-
负责人:Martin L Yarmush
-
依托单位:
Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical En
-
批准号:8265155
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2012
-
负责人:Martin L Yarmush
-
依托单位:
Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical En
-
批准号:8726984
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2012
-
负责人:Martin L Yarmush
-
依托单位:
Merging Innovation, Translational Medicine, and Entrepreneurship in Biomedical En
-
批准号:9134519
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2012
-
负责人:Martin L Yarmush
-
依托单位:
Cellular Composite Device for Combination Therapy of Acute Liver Failure
-
批准号:7771273
-
项目类别:
-
资助金额:$22.09万
-
财政年份:2010
-
负责人:Martin L Yarmush
-
依托单位:
Cellular Composite Device for Combination Therapy of Acute Liver Failure
-
批准号:8063890
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2010
-
负责人:Martin L Yarmush
-
依托单位:
Recellularization of Liver Bioscaffolds
-
批准号:8699188
-
项目类别:
-
资助金额:$52.45万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Recellularization of Liver Bioscaffolds
-
批准号:8502653
-
项目类别:
-
资助金额:$50.62万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Extended Storage of Tissues and Organs in Subzero Environments
-
批准号:8231028
-
项目类别:
-
资助金额:$3.27万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Recellularization of Liver Bioscaffolds
-
批准号:8183616
-
项目类别:
-
资助金额:$63.3万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Extended Storage of Tissues and Organs in Subzero Environments
-
批准号:7691150
-
项目类别:
-
资助金额:$62.45万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Recellularization of Liver Bioscaffolds
-
批准号:7925812
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Extended Storage of Tissues and Organs in Subzero Environments
-
批准号:8292234
-
项目类别:
-
资助金额:$61.6万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Extended Storage of Tissues and Organs in Subzero Environments
-
批准号:8063666
-
项目类别:
-
资助金额:$63.36万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Metabolic Engineering for Improved Liver Function
-
批准号:7905588
-
项目类别:
-
资助金额:$10.01万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Recellularization of Liver Bioscaffolds
-
批准号:7696149
-
项目类别:
-
资助金额:$41.17万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Recellularization of Liver Bioscaffolds
-
批准号:8327699
-
项目类别:
-
资助金额:$54.79万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Extended Storage of Tissues and Organs in Subzero Environments
-
批准号:7891332
-
项目类别:
-
资助金额:$63.67万
-
财政年份:2009
-
负责人:Martin L Yarmush
-
依托单位:
Training in Stem Cell Research
-
批准号:7187329
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2006
-
负责人:Martin L Yarmush
-
依托单位:
海外基金